[HTML][HTML] Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits
Background Patients with peripheral artery disease (PAD) requiring lower extremity
revascularization (LER) have a high risk of adverse limb and cardiovascular events. The …
revascularization (LER) have a high risk of adverse limb and cardiovascular events. The …
Effect of rivaroxaban and aspirin in patients with peripheral artery disease undergoing surgical revascularization: insights from the VOYAGER PAD trial
ES Debus, MR Nehler, N Govsyeyev, RM Bauersachs… - Circulation, 2021 - Am Heart Assoc
Background: Patients with peripheral artery disease requiring lower extremity
revascularization (LER) are at high risk of adverse limb and cardiovascular events. The …
revascularization (LER) are at high risk of adverse limb and cardiovascular events. The …
Total ischemic event reduction with rivaroxaban after peripheral arterial revascularization in the VOYAGER PAD trial
Background Patients with peripheral artery disease (PAD) undergoing lower extremity
revascularization (LER) are at high risk of major adverse limb and cardiovascular events …
revascularization (LER) are at high risk of major adverse limb and cardiovascular events …
Rivaroxaban and risk of venous thromboembolism in patients with symptomatic peripheral artery disease after lower extremity revascularization
Importance Prior studies have observed an association between the burden of
atherosclerotic vascular disease and the risk of venous thromboembolism (VTE). The …
atherosclerotic vascular disease and the risk of venous thromboembolism (VTE). The …
Rivaroxaban in peripheral artery disease after revascularization
Background Patients with peripheral artery disease who have undergone lower-extremity
revascularization are at high risk for major adverse limb and cardiovascular events. The …
revascularization are at high risk for major adverse limb and cardiovascular events. The …
Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease …
Background Patients with peripheral artery disease (PAD) undergoing a lower-extremity
revascularization are at heightened risk for ischemic cardiac and limb events. Although …
revascularization are at heightened risk for ischemic cardiac and limb events. Although …
Efficacy and safety of rivaroxaban therapy for patients with peripheral artery disease: a systematic review and meta-analysis
Y Hao, W Han, D Mou, J Wang - Vascular and Endovascular …, 2021 - journals.sagepub.com
Objective: We performed a systematic review and meta-analysis to evaluate the efficacy and
safety of rivaroxaban in patients with PAD for the first time. Methods: We searched …
safety of rivaroxaban in patients with PAD for the first time. Methods: We searched …
Efficacy and safety of rivaroxaban versus placebo after lower extremity bypass surgery: A post hoc analysis of a “CASPAR like” outcome from VOYAGER PAD
Abstract Background The Clopidogrel and Acetylsalicylic Acid in Bypass Surgery for
Peripheral Arterial Disease (CASPAR) trial is the only large, double‐blind, placebo …
Peripheral Arterial Disease (CASPAR) trial is the only large, double‐blind, placebo …
Rivaroxaban plus aspirin versus aspirin alone after endovascular revascularization for symptomatic PAD: insights from VOYAGER PAD
J Rymer, SS Anand, E Sebastian Debus, LP Haskell… - Circulation, 2023 - Am Heart Assoc
BACKGROUND: Rivaroxaban plus aspirin compared with aspirin alone reduced major
cardiac and ischemic limb events after lower extremity revascularization (LER) in the …
cardiac and ischemic limb events after lower extremity revascularization (LER) in the …
Rivaroxaban and aspirin in peripheral artery disease lower extremity revascularization: impact of concomitant clopidogrel on efficacy and safety
Background: The VOYAGER PAD trial (Vascular Outcomes Study of ASA Along With
Rivaroxaban in Endovascular or Surgical Limb Revascularization for Peripheral Artery …
Rivaroxaban in Endovascular or Surgical Limb Revascularization for Peripheral Artery …
相关搜索
- artery disease rivaroxaban and aspirin
- artery disease extremity revascularization
- artery disease efficacy and safety
- artery disease voyager pad
- artery disease venous thromboembolism
- safety of rivaroxaban voyager pad
- symptomatic pad endovascular revascularization
- symptomatic pad aspirin alone
- extremity revascularization rivaroxaban and aspirin
- effect of rivaroxaban aspirin in patients
- extremity revascularization venous thromboembolism
- artery disease concomitant clopidogrel
- artery disease rationale and design
- artery disease meta analysis
- artery disease rivaroxaban in patients
- artery disease rivaroxaban therapy